News and Announcements
Shivom to feature in CNBC’s Advancements series following the Alpha public release
- Published December 03, 2018 12:00AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
KEY TAKEAWAYS:
- The Shivom team are thrilled to launch their Alpha technology with the public.
- The company will feature in CNBC’s Advancements hosted by Ted Danson.
- Shivom’s CEO gave a keynote speech as the Digital Freedom Festival in Riga.
The Shivom team are excited to launch their Alpha with the public.
The team has been working tirelessly on the launch of the Alpha product which aims to showcase one of the companies USP’s – secure storage of DNA data.
The Alpha product enables individuals to control and access their genomic data.
Shivom will be featuring in CNBC’s Advancements hosted by Ted Danson. Advancements is an educational series dedicated to informing the public about the latest innovations taking place today.
Advancements explores the significant issues impacting society and aim to uncover the best kept secrets to raise social awareness.
Shivom’s feature on the programme will take place on Sunday December 16th and will bring further awareness to the Shivom brand and their tech innovations.
Shivom’s CEO, Henry Ines gave a keynote speech at the Digital Freedom Festival in Riga, Latvia last week.
The festival unites the world of technology and encourages debate on how technologies can make the world a better place.
Henry gave a keynote speech titled “The Future of Health: Reinvention of Healthcare & Wellness” and launched their Alpha public release at the event.
Upcoming Events for Shivom
- Genesis 2018 – Dec 12 to Dec 13
- PMWC 2018 – Dec 23 to Jan 21
- Bockchain Applications for Pharma – Jan 23 to Jan 24
About Shivom
Shivom combines blockchain, A.I., DNA sequencing & cryptography to enable secure and personalized medicine. The Shivom platform works on collaboration & integrity, allowing people to own, manage and monetize their data. By creating a web-marketplace, a network of genomic counsellors, and a not-for-profit drug research unit, Shivom will build a global healthcare ecosystem, reaching even low-income countries.
Company Updates
The Index Approach in Early-Stage Venture Capital: Reconsidered
The venture capital (VC) landscape is marked by its dynamism and complexity, especially in early-stage investing. The traditional approach in VC, characterised by a selective and intensive vetting process, often contrasts with the concept of ‘index investing.’ This article revisits the indexing approach in early-stage VC, incorporating insights from recent studies and data, including a […]
The Future Is Now: The Evolution of Dealflow with Wholesale Investor
If you’ve ever thought of investing or expanding your portfolio, there’s no better time than the present. In the fast-paced world of investment, things are changing at a breathtaking speed, and it’s crucial to stay ahead of the game. The Future of Deal Flow is Today Dealflow, the lifeblood of the investment world, is not […]
Investability of a Startup: A Comprehensive Guide for Angels and High-Net Worth Investors
Venturing into the Startup Scene Let’s dive into the intriguing world of startups. It’s a thrilling ride, isn’t it? Like finding a pearl in an ocean, spotting a promising startup amidst a sea of businesses is no easy task. This guide aims to light the way, focusing on the “The Investability of a Startup: 7 […]
Backed By Leading Investment Groups and Family Offices
